{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "H. R. 3877"}, "official-title": {"#tail": "\n  ", "#text": "To amend title XVIII of the Social Security Act to provide for Medicare coverage of certain lymphedema compression treatment items as items of durable medical equipment."}, "session": {"#tail": "\n    ", "#text": "2d Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20140115", "#text": "January 15, 2014"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and Means"}], "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Reichert", "@name-id": "R000578"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Blumenauer", "@name-id": "B000574"}, {"#tail": ", and ", "#text": "Mr. Lance", "@name-id": "L000567"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Braley of Iowa", "@name-id": "B001259"}]}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HB8AE841F59D8457081A75B3FA48985D4", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Lymphedema Treatment Act"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HD3485329A6AD45C6A499152338080F65"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " makes the following findings:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Lymphedema is a chronic disease that results in an accumulation of protein-rich lymph fluid in parts of the body where lymph nodes or lymphatic vessels are damaged or inadequate.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H5404083451BB4F5F993E14E75C1519D9", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Lymphedema afflicts millions of Americans, including men, women, and children who can be born with a primary form of lymphedema. The majority of cases, however, are secondary forms of lymphedema most often caused by cancer treatments that damage the body\u2019s lymph transport and immune functions."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HE2A42CA873A249639C2185449440E87F", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": {"#tail": ". The study reported an overall cancer-related lymphedema incidence rate of 15.5 percent, with specific rates as follows: sarcoma 30 percent, breast 20 percent, gynecological 20 percent, melanoma 16 percent, genital-urinary 10 percent, and head and neck 4 percent. Risk increased 22 percent after pelvic lymph node removal and 31 percent after radiation therapy.", "#text": "lymphedema is a common post-treatment condition [and] has been described as one of the most significant survivorship issues"}, "#text": "A 2010 peer-reviewed study in the American Cancer Society\u2019s Cancer journal stated ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HC8C198B6636140479D38AAFEE8D351E7", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Lymphedema is progressive when left untreated or under-treated and can put patients at greater risk for serious infections or other costly complications."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H7CE3636264D047ACB6B0930E35F7E6F2", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " acknowledged the importance of comprehensive lymphedema treatment coverage with passage of the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", which requires group health plans, insurance companies, and health maintenance organizations to cover breast cancer-related lymphedema treatment post mastectomy and reconstruction.", "@entity-type": "act", "#text": "Women\u2019s Health and Cancer Rights Act of 1998", "@value": "Women\u2019s Health and Cancer Rights Act of 1998"}], "#text": "\n          "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HD57BAC77037248F78E4D65001DFDD6AE", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Medicare beneficiaries with lymphedema currently lack coverage for compression therapy, an essential component of care they must use to manage their chronic disease. As a result, many patients cannot maintain their condition and experience an unnecessary loss of health and of function in the activities of daily living."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "H4B9A5F32544C4476BD34AA8D1EA9D114", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "This Medicare coverage gap should be closed to help provide improved health care for lymphedema patients and in turn decrease the incidence of costly complications, co-morbidities and related disabilities."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H0E6DB0CCC8964375BCF04147D2683E80", "#text": "\n        "}], "#text": "\n      ", "@id": "H64F173574813436AA0FF9144579A9BB3"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Medicare coverage of certain lymphedema compression treatment items as items of durable medical equipment"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1861 of the Social Security Act", "@value": "Social Security Act/s:1861"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395x", "@value": "usc/42/1395x"}, "@parsable-cite": "usc/42/1395x", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", in the first sentence, by inserting before the semicolon the following: ", "@entity-type": "act", "#text": "subsection (n)", "@value": "Social Security Act/s:1861/ss:n"}, "#text": "in ", "quote": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ")", "@entity-type": "act", "#text": "subsection (iii)", "@value": "Social Security Act/s:1861/ss:iii", "@proposed": "true"}, "#text": "and includes lymphedema compression treatment items (as defined in "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HA4403ED950BE4B31AE993EA06D83F194", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "#text": "by adding at the end the following new subsection:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n        ", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n              ", "term": {"#tail": "\u2014", "#text": "lymphedema compression treatment items"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "header": {"#tail": "\n              ", "#text": "Lymphedema compression treatment items"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "means, with respect to an individual, compression garments, devices, bandaging systems, components, and supplies\u2014"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "#text": "\n                ", "@id": "HF57DD69733884DCE875E40FE43C5375F", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "that are primarily and customarily used in the medical treatment of lymphedema;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HC50F9B5D891E4489B8956C5DB59D344A", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") to the extent authorized under State law); and", "@entity-type": "act", "#text": "section 1861(aa)(5)", "@value": "Social Security Act/s:1861/ss:aa/p:5"}, "#text": "as prescribed by a physician (or a physician assistant, nurse practitioner, or a clinical nurse specialist (as those terms are defined in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H0E75ACF9653B4888AD7EF3E729380153", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", be included as medical and other health services under this title; and", "@entity-type": "act", "#text": "subsection (s)(6)", "@value": "Social Security Act/s:1861/ss:s/p:6"}, "#text": "which would not, other than under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HE6DBD597E34B4BC69E656CCF41096974", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n                ", "#text": "includes\u2014"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H5ABDF533E5D34D0BA5EFDBF360782755", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "multilayer compression bandaging systems;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HE5FBF25C29974E1CB038437A2066C6AF", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "custom or standard fit gradient compression garments;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H0EE3CA580D8B49039B12CFF5AC97ADC4", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "non-elastic and low-elastic compression garments and compression wraps and directional flow pads; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HF3C175C6284647CCBDB99311BEEA8055", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "any other compression garments, bandaging systems, devices, and aids determined by the Secretary to be effective in the prevention or treatment of lymphedema."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "HC0A65BECBF0F485589BBACBB5F9A2E33", "#text": "\n                  "}]}], "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "HACA009EBD55E4B45A4ECD108859304F9"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "H7CBF4843BB7E4D3DAD440B58C0AC71B2"}, "#text": "\n          ", "@id": "HE1A89A60A3FE479DB45CB3800F2E0B89"}], "#text": "\n        ", "@id": "H73FD80C93E3F420CA057B1D0B54D8F11"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply to lymphedema compression treatment items furnished on or after 180 days after the date of the enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Lymphedema Treatment Act/s:3/ss:a", "@proposed": "true"}, "#text": "The amendment made by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "H6AA70B3225574B54822384A12983C5E3"}], "#text": "\n      ", "@id": "HEBC203CB07DD49288A533C111AB07B54"}], "#text": "\n    ", "@id": "HF445847DDECD413B81AFF7FA1D20D18C"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-01-15"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3877 IH: Lymphedema Treatment Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}